CEIDEA Research
CEIDEARESEARCH

Research in context,
evidence in action.

Project background, research scope and expected outcomes.

CASE STUDY
WanTai BiotechCervical CancerVaccine

WanTai - Consumer Research on Cervical Cancer Vaccine Awareness

2021-02-102,378Medical and Pharmaceutical / Consumer Research
Consumer Research on Cervical Cancer Vaccine Awareness

Company overview

Xiamen WanTai Canghai Biotechnology Co., Ltd. is a wholly-owned subsidiary of Beijing WanTai Biopharmaceutical Co., Ltd., a subsidiary of Shengyang Tang Group. The company specializes in the research, development, and promotion of vaccine products. As a key national high-tech enterprise, it is committed to the mission of "providing high-quality, affordable, and innovative vaccines for disease prevention in humans," and has established strategic market positioning, particularly in the promotion of key products such as cervical cancer vaccines.

Research background

As public health awareness increases, cervical cancer vaccines have gradually become a health priority for women. Vaccine acceptance and behavior are influenced by multiple factors, including price perception, product trust, accessibility, and the effectiveness of health education dissemination. To enhance its market positioning and targeted communication, WanTai needs to deeply understand the current level of vaccine awareness, behavioral characteristics, and key decision-driving factors among female consumers, as well as identify behavioral differences between those who have and those who have not received the vaccine.

Research scope

In January 2021, CEIDEA Research was commissioned by WanTai to conduct a survey targeting female populations in Xiamen. The study employed a quantitative questionnaire approach, simultaneously sampling female consumers who had and had not received the cervical cancer vaccine. The research explored their health beliefs, vaccine knowledge, information sources, motivations for vaccination, and barriers to vaccination. Through comparative analysis, a user segmentation profile was developed, uncovering potential market education needs.

Expected outcomes

The research report will provide data support for WanTai Biotech's future market launch, consumer education, and optimization of communication strategies for its cervical cancer vaccine. By accurately mapping the vaccination behaviors and decision-making mechanisms of women in Xiamen, the study will help the company identify target customer segments with precision, allocate resources efficiently, and improve post-market acceptance and communication effectiveness.